We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Newell Brands
NWL
$2.46B
| $34.5M | 0.04% |
778,060
+90,000
| +13% | +$3.53M |
2014 Q1
8 quarters
|
|
177
Standard BioTools
LAB
$258M
| $34.4M | 0.04% |
4,266,432
| – | – |
2013 Q2
11 quarters
|
|
178
Garmin
GRMN
$55B
| $33.6M | 0.03% |
841,500
+92,000
| +12% | +$3.42M |
2015 Q3
2 quarters
|
|
179
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $32.2M | 0.03% |
480,200
| – | – |
2013 Q2
11 quarters
|
|
180
Stryker
SYK
$112B
| $31.7M | 0.03% |
295,500
| – | – |
2013 Q2
11 quarters
|
|
181
DELISTED
Du Pont De Nemours E I
DD
| $30.5M | 0.03% |
482,200
-1,600
| -0.3% | -$95.8K |
2013 Q2
11 quarters
|
|
182
DELISTED
Exact Sciences
EXAS
| $30.4M | 0.03% |
4,516,300
+1,420,000
| +46% | +$9.08M |
2014 Q2
7 quarters
|
|
183
DELISTED
Hawaiian Holdings, Inc.
HA
| $29.9M | 0.03% |
634,500
| – | – |
2014 Q2
7 quarters
|
|
|
RKUS
184
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $29.3M | 0.03% |
2,989,732
+1,446,329
| +94% | +$13.4M |
2015 Q4
1 quarter
|
|
|
TPCO
185
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $27.6M | 0.03% |
3,570,968
-173,175
| -5% | -$1.4M |
2014 Q3
6 quarters
|
|
186
McDonald's
MCD
$172B
| $26.7M | 0.03% |
+212,700
| New | +$25.4M |
2016 Q1
0 quarters
|
|
187
Teradyne
TER
$53.7B
| $26.1M | 0.03% |
1,209,000
+150,000
| +14% | +$2.93M |
2015 Q3
2 quarters
|
|
188
Whirlpool
WHR
$1.83B
| $25.5M | 0.03% |
141,600
-190,000
| -57% | -$28.3M |
2013 Q2
11 quarters
|
|
|
MNTA
189
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $25.3M | 0.03% |
2,738,900
| – | – |
2013 Q2
11 quarters
|
|
190
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $25.2M | 0.03% |
982,400
+35,834
| +4% | +$688K |
2015 Q3
2 quarters
|
|
191
Salesforce
CRM
$203B
| $24.6M | 0.03% |
332,860
+15,400
| +5% | +$1.06M |
2013 Q2
11 quarters
|
|
|
SZYM
192
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $24.5M | 0.03% |
12,057,284
-5,800
| -0% | -$10.3K |
2013 Q2
11 quarters
|
|
193
Hilton Worldwide
HLT
$77.2B
| $24.4M | 0.03% |
360,933
+206,266
| +133% | +$12.3M |
2015 Q2
3 quarters
|
|
|
PFNX
194
DELISTED
Pfenex Inc.
PFNX
| $23.9M | 0.02% |
2,431,388
| – | – |
2015 Q2
3 quarters
|
|
195
HubSpot
HUBS
$11.9B
| $22.5M | 0.02% |
+515,000
| New | +$22.1M |
2016 Q1
0 quarters
|
|
196
DELISTED
Diebold Nixdorf Incorporated
DBD
| $22.1M | 0.02% |
766,000
+115,000
| +18% | +$3.01M |
2013 Q2
11 quarters
|
|
197
Marriott International
MAR
$101B
| $21.4M | 0.02% |
300,000
+180,000
| +150% | +$11.8M |
2015 Q3
2 quarters
|
|
198
Comcast
CMCSA
$77.3B
| $21M | 0.02% |
687,934
+301,934
| +78% | +$8.67M |
2015 Q3
2 quarters
|
|
|
GUID
199
DELISTED
Guidance Software, Inc.
GUID
| $19.7M | 0.02% |
4,585,315
| – | – |
2013 Q2
11 quarters
|
|
200
Republic Services
RSG
$70.3B
| $18.7M | 0.02% |
392,935
+9,000
| +2% | +$408K |
2013 Q2
11 quarters
|
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.